AGL/FFIE/HALO
AGL/FFIE/HALO
Description
- XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
- 52 Week Range14.36 - 39.10CFO: Tim BensleySubsidiary: Agilon Health Management, inc.Founded: 2016Headquarters: Austin, TXNumber of employees: 647 (2021)
- Volume
3,342,444 - Avg. Volume2,074,058
mbol Last Price Change % Change 73.38 +1.58 +2.20% 159.61 +1.17 +0.74% 3.7800 -0.0400 -1.05% 87.15 +2.97 +3.53% 24.29 +0.08 +0.33
Market Cap 10.555B Beta (5Y Monthly) N/A
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXX52 Week Range 1.65 - 17.00 Volume 62,585,812 Avg. Volume 5,360,061
Market Cap 1.663B Beta (5Y Monthly) N/
1
- FFIE 5.50
mbol Last Price Change % Change 1.0700 +0.0500 +4.90% 9.60 +0.16 +1.69% 3.2900 -0.4100 -11.08% 32.44 +1.70 +5.53% 2.4300 +0.2900 +13.55
Sector(s): Consumer Cyclical
Industry: Auto Manufacturers
Full Time Employees: 745
2 Week Range 31.36 - 51.13 Volume 2,981,123 Avg. Volume 1,106,888
Market Cap 6.921B Beta (5Y Monthly) 1.23
ymbol Last Price Change % Change 55.45 +0.53 +0.97% 31.48 -0.39 -1.22% 240.20 -1.70 -0.70% 80.78 +1.06 +1.33% 75.18 0.00 0.00%
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 145
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
mbol | Last Price | Change | % Change |
---|---|---|---|
Market Cap | 10.555B |
Beta (5Y Monthly) | N/A |
52 Week Range | 1.65 - 17.00 |
Volume | |
Avg. Volume | 5,360,061 |
| 1 |
mbol | Last Price | Change | % Change |
---|---|---|---|
Sector(s): Consumer Cyclical
Industry: Auto Manufacturers
Full Time Employees: 745
2 Week Range | 31.36 - 51.13 |
Volume | |
Avg. Volume | 1,106,888 |
Market Cap | 6.921B |
Beta (5Y Monthly) | 1.23 |
ymbol | Last Price | Change | % Change |
---|---|---|---|
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 145
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Healthcare Finance and Accounting
Providing adequate healthcare to patients is only possible in a fiscally responsible environment. Finance, accounting, statistics, and budgeting are some of the primary foci for those working in healthcare management. Virtually all healthcare management degree programs feature a course in accounting; however, the course may also include lessons in finance and other details related to medical budgeting. Topics covered may include the balance of inpatient and outpatient investment, value-based payments, and investment in cybersecurity.
https://www.healthcare-management-degree.net/best/online-masters-programs/
https://www.utdallas.edu/fact-sheets/jsom/bs-healthcare-management/
Providing adequate healthcare to patients is only possible in a fiscally responsible environment. Finance, accounting, statistics, and budgeting are some of the primary foci for those working in healthcare management. Virtually all healthcare management degree programs feature a course in accounting; however, the course may also include lessons in finance and other details related to medical budgeting. Topics covered may include the balance of inpatient and outpatient investment, value-based payments, and investment in cybersecurity.
https://www.healthcare-management-degree.net/best/online-masters-programs/
https://www.utdallas.edu/fact-sheets/jsom/bs-healthcare-management/
No comments:
Post a Comment